Euromedissp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2009-07-21
Share capital
3,990,000.00 PLN
Activity description

Euromedis is a medical center in Szczecin, operating since 2009 and providing care for adults and children, including services covered by Poland’s National Health Fund. Its services include diagnostics, treatment, rehabilitation, care for people with memory disorders, and clinical trials.

Registered address
Powstańców Wielkopolskich 33A, 70-111 Szczecin, Poland
Phone
Social media
Electronic delivery address
AE:PL-28831-13005-IUBGT-21

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 88 days late).

  • 202514/07/2026
  • 202414/07/2025
  • 202306/07/2024
  • 202211/07/2023
  • 202111/10/2022
  • 202028/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.68mMedianUSD 73.59kAverageUSD 3.23m
Net profit
This companyUSD -436.35kMedianUSD 68.18AverageUSD 82.15k
Operating costs
This companyUSD 1.90mMedianUSD 76.09kAverageUSD 3.04m
Assets
This companyUSD 2.90mMedianUSD 120.07kAverageUSD 3.90m

National Health Fund (NFZ) contracts

Euromedis has been an NFZ healthcare provider since 2009. In 2026 it is performing 1 contract worth USD 84.56k. All its contracts were worth USD 1.95m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Outpatient specialist carezachodniopomorskie1USD 84.56k

NFZ waiting lists

This company's facilities run 1 NFZ waiting list. Waiting time forecast by NFZ, as of .

ServiceWaiting time
Neurology services–

Authorized Representatives

Jerzy Krzysztof Kolenda – Management Board Member
Marcin Mirosław Ratajczak – Management Board Member

Manner of representation

Each member of the management board is authorized to sign and make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Jerzy Krzysztof Kolendaage 48
20,229$546,434.3650.6992%
Marcin Mirosław Ratajczakage 48
19,671$531,334.4149.2982%
Others
1$27.010.0026%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2011-06-30.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

17 public aid cases recorded, with a total value of $385,946.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$27,832
De minimis aid (in accordance with Commission Regulation 2023/2831)
$3,516
De minimis aid (in accordance with Commission Regulation 2023/2831)
$169.5K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Gryfitlabsp. z o.o.
MideroS.A.
Pure Clinicalsp. z o.o.
Eurxsp. z o.o.
Laboratorium Analiz Chemicznych Spark-Labsp. z o.o.
Medsource Polskasp. z o.o.
QWEDsp. z o.o.
Laboratorium Badawcze Sorbolabsp. z o.o.
Sonovero R&Dsp. z o.o.
Gispro Technologiessp. z o.o.

Change history

DateEvent
2025-09-08Share capital increase
2024-01-16Share capital increase
2020-09-30PKD change
2017-12-28Share capital increase
2014-05-23Address change

FAQ

Last updated: 2026-07-15